Raul Pellini1, Valentina Manciocco1, Mario Turri-Zanoni2, Antonello Vidiri3, Giuseppe Sanguineti4, Laura Marucci4, Rosa Sciuto5, Renato Covello6, Isabella Sperduti7, Ramy Kayal3, Vincenzo Anelli3, Barbara Pichi1, Giuseppe Mercante1, Giuseppe Spriano1. 1. Department of Otolaryngology - Head & Neck Surgery, National Cancer Institute Regina Elena, Rome, Italy. 2. Department of Otolaryngology - Head & Neck Surgery, National Cancer Institute Regina Elena, Rome, Italy. Electronic address: tzmario@inwind.it. 3. Department of Radiology, National Cancer Institute Regina Elena, Rome, Italy. 4. Department of Radiotherapy, National Cancer Institute Regina Elena, Rome, Italy. 5. Department of Nuclear Medicine, National Cancer Institute Regina Elena, Rome, Italy. 6. Department of Pathology, National Cancer Institute Regina Elena, Rome, Italy. 7. Department of Biostatistics, National Cancer Institute Regina Elena, Rome, Italy.
Abstract
OBJECTIVE: To investigate the ability of neck ultrasounds (US), magnetic resonance imaging (MRI) and positron emission tomography (FDG-PET/TC) in detecting residual nodal disease after chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma (OPSCC). METHODS: From 2006 to 2009, 36 consecutive patients affected by OPSCC with bulky nodal disease (>3 cm), treated with primary concurrent chemoradiotherapy, were enrolled prospectively. Nodal response to treatment was assessed by using US, MRI and FDG-PET/CT. Planned neck dissection (ND) was performed in all the patients, and the histopathological node status was compared to the imaging findings in order to establish sensitivity, specificity, accuracy and predictive values of each technique. RESULTS: Metastatic disease was assessed in 18/37 (48.6%) hemi-necks, always localized in levels II-IV. US showed greater sensitivity (77.8%) and, combined with FDG-PET/TC, produced the highest negative predictive value (93.3%). US, MRI and FDG-PET/TC scans showed the highest specificity (100%), accuracy (93.8%) and positive predictive values (100%). CONCLUSIONS: In the presence of advanced OPSCC with bulky nodal disease, US combined with FDG-PET/TC could be a reliable and cost-effective strategy to identify patients with complete nodal response to chemoradiotherapy that might not require post-treatment ND but only observation. When residual disease in the neck was detected, selective ND was recommended.
OBJECTIVE: To investigate the ability of neck ultrasounds (US), magnetic resonance imaging (MRI) and positron emission tomography (FDG-PET/TC) in detecting residual nodal disease after chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma (OPSCC). METHODS: From 2006 to 2009, 36 consecutive patients affected by OPSCC with bulky nodal disease (>3 cm), treated with primary concurrent chemoradiotherapy, were enrolled prospectively. Nodal response to treatment was assessed by using US, MRI and FDG-PET/CT. Planned neck dissection (ND) was performed in all the patients, and the histopathological node status was compared to the imaging findings in order to establish sensitivity, specificity, accuracy and predictive values of each technique. RESULTS:Metastatic disease was assessed in 18/37 (48.6%) hemi-necks, always localized in levels II-IV. US showed greater sensitivity (77.8%) and, combined with FDG-PET/TC, produced the highest negative predictive value (93.3%). US, MRI and FDG-PET/TC scans showed the highest specificity (100%), accuracy (93.8%) and positive predictive values (100%). CONCLUSIONS: In the presence of advanced OPSCC with bulky nodal disease, US combined with FDG-PET/TC could be a reliable and cost-effective strategy to identify patients with complete nodal response to chemoradiotherapy that might not require post-treatment ND but only observation. When residual disease in the neck was detected, selective ND was recommended.
Authors: Johanna Sjövall; Ulrika Bitzén; Elisabeth Kjellén; Per Nilsson; Peter Wahlberg; Eva Brun Journal: Eur J Nucl Med Mol Imaging Date: 2015-10-02 Impact factor: 9.236
Authors: Mehdi Taghipour; Esther Mena; Matthew J Kruse; Sara Sheikhbahaei; Rathan M Subramaniam Journal: Nucl Med Commun Date: 2017-03 Impact factor: 1.690
Authors: R Maquieira; S K Haerle; G F Huber; A Soltermann; S R Haile; S J Stoeckli; Martina A Broglie Journal: Eur Arch Otorhinolaryngol Date: 2015-06-10 Impact factor: 2.503
Authors: Daniel Dejaco; Christian Uprimny; Gerlig Widmann; David Riedl; Patrizia Moser; Christoph Arnold; Teresa Bernadette Steinbichler; Barbara Kofler; Volker Hans Schartinger; Irene Virgolini; Herbert Riechelmann Journal: Cancer Imaging Date: 2020-09-29 Impact factor: 3.909